(HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of uncomplicated urogenital gonorrhea, according to a study published online Dec. 11 in The Lancet.
Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.
Gonorrhea symptoms often clear within one week of starting treatment. Avoid sexual activity during treatment and for seven days after it ends. Ceftriaxone antibiotic injection and oral antibiotics are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback